TScan Therapeutics, Inc. (TCRX)
1.01
-0.02
(-1.94%)
USD |
NASDAQ |
Apr 02, 16:00
1.015
0.00 (0.00%)
After-Hours: 20:00
TScan Therapeutics Market Cap : 56.63M for April 2, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Lexicon Pharmaceuticals, Inc. | 653.11M |
| Agios Pharmaceuticals, Inc. | 2.124B |
| Sutro Biopharma, Inc. | 374.33M |
| Recursion Pharmaceuticals, Inc. | 1.672B |
| ACADIA Pharmaceuticals, Inc. | 3.764B |
Market Cap Related Metrics
| PS Ratio | 12.51 |
| Price to Book Value | 0.4600 |
| Price | 1.01 |
| Earnings Yield | -100.5% |